TISSUEBLUE (Brilliant Blue G) Patent Expiration, LOE Window & CMS Spending

TISSUEBLUE (Brilliant Blue G) by Dutch Ophthalmic Research Center International Bv: FDA Orange Book LOE 2026-12-20, 0 AB generics, $0 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorDutch Ophthalmic Research Center International Bv
FDA Application & PathwayN209569 (NDA)
Exclusivity / Cliff HorizonImmediate Cliff (2025-2027)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2026-12-20
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$0
2024 Medicare Part D Spend$0
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel